Aclaris Therapeutics shares owned by Frazier Life Sciences Management
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Frazier Life Sciences Management
from 13F filings
Historical chart of Frazier Life Sciences Management investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by Frazier Life Sciences Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aclaris Therapeutics by Frazier Life Sciences Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $19M | 4.9M | 3.75 |
| 2024-09-30 | $304k | 264k | 1.15 |
| 2024-06-30 | $291k | 264k | 1.10 |
| 2024-03-31 | $328k | 264k | 1.24 |
| 2023-12-31 | $278k | 264k | 1.05 |
| 2023-09-30 | $1.8M | 264k | 6.85 |
| 2023-06-30 | $2.7M | 264k | 10.37 |
| 2023-03-31 | $2.1M | 264k | 8.09 |
| 2022-12-31 | $4.6M | 290k | 15.75 |
| 2022-09-30 | $6.4M | 408k | 15.74 |
| 2022-06-30 | $5.7M | 408k | 13.96 |
| 2022-03-31 | $7.0M | 408k | 17.24 |
More positions owned by Frazier Life Sciences Management
View all positions for Frazier Life Sciences Management